See also this year's filing and all EDGAR filings for this company.
PDF Report 0000822411_2016_EOM_Pharmaceutical_Holdings_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 2.684711980886561, 'aggregate_val': 8362078, 'exp_sum': 2269398, 'exp_to_value': {'LiabilitiesCurrent': 2269398, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 0}} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 2.3215292766806948, 'aggregate_val': 10758244, 'exp_sum': 3238943, 'exp_to_value': {'LiabilitiesCurrent': 3238943, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0000822411, EOM Pharmaceutical Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 24,560,538 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 180,922 |
| 3 | remainder_Assets | 5,340,914 |
| 4 | LiabilitiesCurrent | 2,269,398 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 6,092,680 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,617,875 |
| 9 | ResearchAndDevelopmentExpense | 10,578,670 |
| 10 | remainder_Expenses | 208,831 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,752,143 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 30,082,374 |
| 1 | Liabilities | 8,362,078 |
| 2 | Expenses | 15,405,376 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 21,720,296 |
| 5 | NetIncome | -13,653,233 |
| 6 | ComprehensiveNetIncome | -13,653,233 |
| 7 | BaseVar | 27,800,986 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.75 |
| 9 | EconomicCapitalRatio | 2.86 |
Edgar->Model Mapping
Feature Distribution
Change over Time
